Congestive heart failure remains one of the leading causes of cardiac death and disability. As pharmacological therapies have advanced, patients are living longer and more productive lives. However, at some point, these interventions begin to fail. Circulatory assist devices have revolutionized the management of patients with end-stage heart disease. These devices successfully bridge patients to cardiac transplantation. The Syncardia Total Artificial Heart provides biventricular support for the failing heart. This case study illustrates the challenges of caring for patients with such a device.
Get full access to this article
View all access options for this article.
References
1.
CopelandJGArabiaFTsauPH. Total artificial hearts: Bridge to transplantation. Cardiol Clin.2003;21(1):101–113.
2.
JoyceLDDeVriesWCHastingsWLOlsenDBJarvikRKKolffWJ. Response of the human body to the first permanent implant of the Jarvik-7 Total Artificial Heart. Trans Am Soc Artif Intern Organs.1983;29:81–87.
3.
SlepianMJSmithRGCopelandJG. The SynCardia CardioWest Total Artificial Heart. In: BaughmanKBaumgartnerW, eds. Treatment of Advanced Heart Disease.New York, NY: Taylor and Francis Group; 2006:473–490.
4.
CopelandJGSmithRGArabiaF. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med.2004;351(9):859–867.
5.
El-BanayosyAArusogluLMorshuisM. Cardio West Total Artificial Heart: Bad Oeynhausen experience. Ann Thoracic Surg.2005;80(2):548–552.
6.
LeprincePBonnetNRamaA. Bridge to transplantation with Jarvik-7 (CardioWest) total artificial heart: A single center 15-year experience. J Heart Lung Transplant.2003; 22(12):1296–1303.
7.
SavageL. Quality of life among patients with a left ventricular assist device: What is new?AACN Clin Issues.2003;14(1)64–72.
